Organs

ProMind Complex Review: New Brain Boosting Supplement to Improve Memory

Retrieved on: 
Monday, January 11, 2021

The working of the ProMind Complex on the brain is quite complicated, primarily because of the brain's complexity.

Key Points: 
  • The working of the ProMind Complex on the brain is quite complicated, primarily because of the brain's complexity.
  • ProMind Complex optimizes the brain functions by activating all required brain pathways.
  • Unlike other nootropics that tend to have side effects on the brain, ProMind Complex is risk-free and safe for daily consumption.
  • In only a few years after its launch, ProMind Complex has already become a big name in the supplement industry .

New on Public Television: The Brain Revolution

Retrieved on: 
Monday, November 23, 2020

The program will delve into Dr. Merzenichs lifelong study of how to achieve and maintain a healthy and high performing brain.

Key Points: 
  • The program will delve into Dr. Merzenichs lifelong study of how to achieve and maintain a healthy and high performing brain.
  • At that time, their first such special, The Brain Fitness Program , became the most successful fundraiser in public television history.
  • His work showing the brain remains plastic overturned existing models about how the brain works and began a still unfolding revolution in our understanding of the brain.
  • Dr. Merzenich then pioneered how computers might be used to measure brain function, deliver the right stimuli in brain exercises, and drive the brain in a positive direction.

Merck Manuals Shares 5 Tips to Prevent and Reduce Heartburn

Retrieved on: 
Thursday, November 19, 2020

Heartburn is a common symptom of gastroesophageal reflux disease (GERD), which develops when reflux of gastric contents in the esophagus causes troublesome symptoms and/or complications.

Key Points: 
  • Heartburn is a common symptom of gastroesophageal reflux disease (GERD), which develops when reflux of gastric contents in the esophagus causes troublesome symptoms and/or complications.
  • Dr. Lynch also shares five ways to reduce heartburn and GERD symptoms.
  • By four hours after a meal, around 90 percent of the food in your stomach has been digested.
  • Avoid lying down during that time including on the couch to help digestion and minimize heartburn.

MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020

Retrieved on: 
Friday, November 13, 2020

Specifically, the studies evaluated the effect of PDE4 inhibitors on attenuating fibrotic processes with an emphasis on HSC activation.

Key Points: 
  • Specifically, the studies evaluated the effect of PDE4 inhibitors on attenuating fibrotic processes with an emphasis on HSC activation.
  • Yuichi Iwaki, MD, PhD, President and Chief Executive Officer of MediciNova, Inc. commented, We are very pleased with the positive findings in an acute liver injury model study conducted by Dr. Gobejishvili and Dr. McClain.
  • We look forward to advancing to the next step to further investigate the potential of MN-001 in liver fibrosis.
  • The attenuation of TGF1 signaling for HSC activation and the anti-fibrogenic effect in an acute liver injury model by MN-001 was very promising.

Global Cardiac Mapping Market Report 2020-2025

Retrieved on: 
Tuesday, November 10, 2020

DUBLIN, Nov. 10, 2020 /PRNewswire/ -- The "Global Cardiac Mapping Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 10, 2020 /PRNewswire/ -- The "Global Cardiac Mapping Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The factors such as increasing incidence of cardiovascular diseases is expected to propel the cardiac mapping market.
  • However, the lack of skilled & experienced electrophysiologists along with the costs associated with the cardiac mapping procedure may restrain the market to an extent during the forecast period.
  • The Global Cardiac Imaging Market can be segmented on the basis of technology, end user, indication and geography.

LearningRx® Brain Training Centers Partner with Award-Winning Children's Author

Retrieved on: 
Thursday, November 5, 2020

COLORADO SPRINGS, Colo., Nov. 5, 2020 /PRNewswire/ --LearningRx, the world's largest personal brain training company, has partnered with an award-winning author to launch a new book that helps students overcome learning (and life!)

Key Points: 
  • COLORADO SPRINGS, Colo., Nov. 5, 2020 /PRNewswire/ --LearningRx, the world's largest personal brain training company, has partnered with an award-winning author to launch a new book that helps students overcome learning (and life!)
  • "Our 109,000+ clients have experienced life-changing results from one-on-one personal brain training, which not only yielded stronger brain skills, but also a huge boost in our graduates' confidence.
  • LearningRx Marketing & Media Relations Director Lisa Juhl is available for interviews and can discuss:
    How brain training has helped more than 100,000 LearningRx graduates learn easier, think faster, and perform better
    Brain training programs available for people with ADHD/attention issues, reading/dyslexia challenges, memory decline, learning differences, and more
    LearningRx, headquartered in Colorado Springs, Colorado, is the largest one-on-one brain training company in the world.
  • To learn more visit https://www.learningrx.com
    LearningRx Brain Training | Colorado Springs, CO | 719.660.5312 | [email protected]
    View original content to download multimedia: http://www.prnewswire.com/news-releases/learningrx-brain-training-center...

North America Liver Disease Treatment Market to Hit $8.31 Bn, by 2027, at 5.2% CAGR: AMR

Retrieved on: 
Tuesday, October 27, 2020

Additionally, the lack of healthcare professionals for liver disease treatment has further impacted the market.

Key Points: 
  • Additionally, the lack of healthcare professionals for liver disease treatment has further impacted the market.
  • Based on treatment type, the antiviral drugs segment dominated the market in 2019, accounting for more than half of the North America liver disease treatment market.
  • On the basis of disease type, the hepatitis segment held the largest share in 2019, accounting for more than four-fifths of the North America liver disease treatment market.
  • The market across U.S. held the lion's share in 2019, contributing to more than four-fifths of the North America liver disease treatment market.

InventHelp Inventors Develop Seat Cushion to Keep the Groin Cool and Comfortable (OCC-1525)

Retrieved on: 
Monday, October 12, 2020

The invention provides an effective way to keep the groin area cool and comfortable while sitting.

Key Points: 
  • The invention provides an effective way to keep the groin area cool and comfortable while sitting.
  • In doing so, it eliminates the need to feel hot, itchy and agitated when seated for an extended period of time.
  • As a result, it could help to reduce pain and other issues associated with hemorrhoids and colon problems and it provides added peace of mind.
  • The original design was submitted to the Orange County sales office of InventHelp.

Zai Lab Announces First Patient Dosed in Greater China in the Global Phase 2/3 MAHOGANY Study of Margetuximab in Gastric and Gastroesophageal Junction Cancer

Retrieved on: 
Tuesday, October 6, 2020

Gastroesophageal adenocarcinoma is the fifth and second most common tumor type worldwide and in China, respectively.

Key Points: 
  • Gastroesophageal adenocarcinoma is the fifth and second most common tumor type worldwide and in China, respectively.
  • The primary outcome measure for efficacy is objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST).
  • Cancer of the stomach (gastric cancer) or the gastroesophageal junction (where the esophagus joins the stomach) is collectively known as gastroesophageal adenocarcinoma.
  • In 2019, Incyte and Zai Lab announced a collaboration and license agreement for the development and commercialization of retifanlimab in Greater China.

Kerecis to Donate its FDA-Approved Fish Skin Treatment for Burn Victims of West Coast Fires

Retrieved on: 
Monday, September 14, 2020

Kerecis, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, is donating its Kerecis Omega3 Burn product for burn victims of the fires in California, Oregon and Washington.

Key Points: 
  • Kerecis, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, is donating its Kerecis Omega3 Burn product for burn victims of the fires in California, Oregon and Washington.
  • These horrific fires are having a devastating effect on human lives and habitat, said G. Fertram Sigurjonsson, founder and CEO of Kerecis.
  • Kerecis Omega3 Burn is intact fish skin that, when grafted onto damaged human tissue, recruits the bodys own cells and ultimately is converted into living tissue.
  • Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal skin substitute.